(Q28264682)

9

object named as

Eliezer Masliah

0 references

author name string

Kohichi Kawahara

1

0 references

Makoto Hashimoto

2

0 references

Pazit Bar-On

3

0 references

Gilbert J Ho

4

0 references

Leslie Crews

5

0 references

Hideya Mizuno

6

0 references

Syed Z Imam

Journal of Biological Chemistry

8

0 references

language of work or name

English

0 references

publication date

14 March 2008

0 references

published in

0 references

volume

283

0 references

issue

11

0 references

page(s)

6979-87

0 references

cites work

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Parkinson disease: etiology, pathogenesis and future of gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Alpha-synuclein and the Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Chaperone-like activity of synucleins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Genetic testing in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Genetic clues to the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Molecular Pathways of Neurodegeneration in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

How does parkin ligate ubiquitin to Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

A disease state mutation unfolds the parkin ubiquitin-like domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Recent advances in the genetics and pathogenesis of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Pathological proteins in Parkinson's disease: focus on the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Molecular pathophysiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Differential effects of Parkin and its mutants on protein aggregation, the ubiquitin-proteasome system, and neuronal cell death in human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Relative sensitivity of parkin and other cysteine-containing enzymes to stress-induced solubility alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Cellular parkin mutants are soluble under non-stress conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Co-association of parkin and alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Altered proteasomal function in sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Ubiquitin-proteasome system and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Reduced neuritic outgrowth and cell adhesion in neuronal cells transfected with human alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

The role of synaptic proteins in the pathogenesis of disorders of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease-linked point mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Parkin accumulation in aggresomes due to proteasome impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Alpha-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

A Caenorhabditis elegans Parkin mutant with altered solubility couples alpha-synuclein aggregation to proteotoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Proteasomal activity in brain differs between species and brain regions and changes with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

The synaptic protein NACP is abnormally expressed during the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

S-nitrosylation in Parkinson's disease and related neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on differentiating mouse N2a neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Rotenone inhibition of tubulin self-assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Parkin gene therapy for alpha-synucleinopathy: a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Parkin counteracts symptoms in a Drosophila model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M710418200

21 January 2018

Identifiers

DOI

10.1074/JBC.M710418200

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

18195004

1 reference

Consolidated OpenCitations Corpus – April 2017